ANALYSIS OF THE INTERNAL MARKET OF MEDICINES USED IN DISEASES OF THE NASAL CAVITY

Authors

DOI:

https://doi.org/10.11603/2312-0967.2021.2.12126

Keywords:

pharmaceutical market, diseases of the nasal cavity, sprays, nasal drops

Abstract

The aim of the work. To analyze the current range of drugs of the pharmaceutical market of Ukraine for the treatment of diseases of the nasal cavity (ATS code R01), taking into account the composition, active substances, dosage forms, manufacturers.

Materials and Methods.  The work was performed using official sources of information, data from which were processed, systematized using statistical, logical and graphical methods.

Results and Discussion. As a result of the analysis, it was found that in the pharmaceutical market of Ukraine most drugs for the treatment of diseases of the nasal cavity are registered in the form of sprays (67.16  %); single-component drugs make up the predominant share of the range (76.12  %). Xylometazoline as the active substance is used most often (35.07  %). Imported drugs dominate the Ukrainian market (62  %). The leader among Ukrainian pharmaceutical companies is PJSC "Farmak" (41.18  %).

Conclusions. Analysis of the market of drugs used in diseases of the nasal cavity, showed that they belong to different pharmacological groups. Both mono- and multicomponent preparations are presented on the market mainly in the form of sprays and drops. The range of Ukrainian drugs is provided by 8 pharmaceutical manufacturers, the leader among which is PJSC "Farmak" (41.18  %).

Author Biographies

N. Ye. Stadnytska, Lviv Polytechnic National University

PhD (Chemistry), Associate Professor of the Department of Technology of Biologically Active Substances

Zh. D. Parashchyn, Lviv Polytechnic National University

PhD (Chemistry), Associate Professor of the Department of Technology of Biologically Active Substances

I. P. Lobur, Lviv Polytechnic National University

assistant of the Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

I. V. Fito, Lviv Polytechnic National University

PhD-student, of the Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

References

European Health for All Statistical Database. URL: http://medstat.gov.ua/ukr/normdoc.html.

Popovych VI. [Acute viral rhinosinusitis: modern views on etiopathogenesis, diagnosis and treatment]. Semeynaya meditsina. 2015;2: 158-60. Ukrainian.

Popovych VI. [Allergic rhinitis: modern approaches to diagnosis and treatment]. Ukrainskyi medychnyi chasopys. 2018;3:(125),V-VI: 64-5. Ukrainian.

Compendium Directory [Internet]. Available from: http:// compendium.com.ua. URL: https://compendium.com.ua.

Chaika LO, Deieva TV, Nikitina NS, Tymchenko OV, Libina VV, Andrianova TV, Bezuhla OP. [Experimental study of the pharmacological activity of mometasone nasal spray with oxymetazoline]. Farmakolohiia ta likarska toksykolohiia. 2018;4-5: 42-52. Available from: http://nbuv.gov.ua/UJRN/flt_2018_4-5_8.

Kukhtenko OS, Hladukh YeV, Simonian LS. [Analysis of the domestic market of drugs for the treatment of inflammatory diseases of the respiratory tract]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2017;4(52): 42-9.

Trykhlib VI., Zadorozhna VI, Tkachuk SI, Palatna LO, Operchuk NI.[ Incidence of acute upper respiratory tract infections of multiple or indeterminate localization among the pediatric population of Ukraine]. Aktualnaya infektologiya. 2016;3: 83-92. Available from: http://nbuv.gov.ua/UJRN/akinf_2016_3_17. Ukrainian.

Bil BN, Kushnir AS, Nazarenko AM [Polydex drugs with phenylephrine and Isofra in the local treatment of rhinological diseases]. Semeynaya meditsina. 2014;1: 85-8. Available from: http://nbuv.gov.ua/UJRN/simmed_2014_1_19. Ukrainian.

State Register of Medicines of Ukraine. [Державний реєстр лікарських засобів України] Available from: http://www.drlz.kiev.ua/ Ukrainian.

Medicine Control. Available from: http://likicontrol.com.ua

Dieieva YuV, Bezshapochnyi SB. [Drugs of local antibacterial therapy as a component of treatment of inflammatory diseases of the nasal cavity and paranasal sinuses]. Visnyk problem biolohii i medytsyny. 2019;1(48): 106-11. Available from:: http://nbuv.gov.ua/UJRN/Vpbm_2019_1 % 281 % 29__24 DOI 10.29254/2077-4214-2019-1-1-148-106-111. Ukrainian.

Downloads

Published

2021-07-14

How to Cite

Stadnytska, N. Y., Parashchyn, Z. D., Lobur, I. P., & Fito, I. V. (2021). ANALYSIS OF THE INTERNAL MARKET OF MEDICINES USED IN DISEASES OF THE NASAL CAVITY. Pharmaceutical Review Farmacevtičnij časopis, (2), 36–43. https://doi.org/10.11603/2312-0967.2021.2.12126

Issue

No. 2 (2021)

Section

Pharmaceutical management, marketing and logistics

License

Copyright (c) 2021 Pharmaceutical Review

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The authors who publish their materials in this journal agree with the following terms:

  • Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal Результат пошуку зображень за запитом "CC-BY logo".
  • Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.

Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).